PMED — Predictmedix AI Income Statement
0.000.00%
Last trade - 00:00- CA$3.76m
- CA$3.76m
- 19
- 12
- 47
- 15
Annual income statement for Predictmedix AI, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.135 | 0.035 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 0.085 | 0.027 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.31 | 1.93 | 2.02 | 2.1 | 1.99 |
| Operating Profit | -2.31 | -1.93 | -1.88 | -2.07 | -1.99 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2.31 | -1.93 | -1.88 | -2.07 | -1.99 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.31 | -1.93 | -1.88 | -2.07 | -1.99 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.29 | -1.58 | -1.88 | -2.07 | -1.99 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.29 | -1.58 | -1.88 | -2.07 | -1.99 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.008 | -0.019 | -0.017 | -0.018 | -0.014 |